Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 19 | 2025 | 627 | 4.820 |
Why?
|
| Carcinoma, Squamous Cell | 12 | 2023 | 756 | 2.340 |
Why?
|
| Tomography, X-Ray Computed | 17 | 2025 | 2095 | 1.830 |
Why?
|
| Mouth Neoplasms | 5 | 2020 | 98 | 1.480 |
Why?
|
| Magnetic Resonance Imaging | 14 | 2025 | 3833 | 1.380 |
Why?
|
| Neoplasm Recurrence, Local | 9 | 2025 | 1270 | 1.340 |
Why?
|
| Positron Emission Tomography Computed Tomography | 6 | 2022 | 76 | 1.290 |
Why?
|
| Diagnostic Imaging | 5 | 2022 | 296 | 1.260 |
Why?
|
| Oropharyngeal Neoplasms | 7 | 2023 | 268 | 1.240 |
Why?
|
| Neck | 6 | 2025 | 145 | 1.170 |
Why?
|
| Image-Guided Biopsy | 2 | 2020 | 42 | 1.130 |
Why?
|
| Radiology | 5 | 2025 | 124 | 1.110 |
Why?
|
| Radiology Information Systems | 4 | 2025 | 26 | 1.070 |
Why?
|
| Papillomavirus Infections | 5 | 2023 | 392 | 0.890 |
Why?
|
| Lymphatic Metastasis | 3 | 2025 | 431 | 0.760 |
Why?
|
| Tongue | 3 | 2021 | 30 | 0.600 |
Why?
|
| Mouth | 2 | 2016 | 66 | 0.580 |
Why?
|
| Patient Access to Records | 1 | 2017 | 12 | 0.550 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 376 | 0.530 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 644 | 0.510 |
Why?
|
| Temporomandibular Joint Disorders | 2 | 2016 | 12 | 0.500 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 137 | 0.490 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 415 | 0.490 |
Why?
|
| Sensitivity and Specificity | 10 | 2025 | 2122 | 0.490 |
Why?
|
| Patient Preference | 1 | 2017 | 147 | 0.480 |
Why?
|
| Positron-Emission Tomography | 4 | 2022 | 294 | 0.440 |
Why?
|
| Neoplasm Staging | 8 | 2022 | 1315 | 0.430 |
Why?
|
| Neuroimaging | 1 | 2017 | 388 | 0.410 |
Why?
|
| Humans | 49 | 2025 | 130931 | 0.400 |
Why?
|
| Communication | 1 | 2017 | 530 | 0.400 |
Why?
|
| Neoplasms, Unknown Primary | 3 | 2021 | 13 | 0.390 |
Why?
|
| Temporomandibular Joint | 1 | 2012 | 11 | 0.380 |
Why?
|
| Research Design | 3 | 2022 | 722 | 0.370 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2012 | 50 | 0.350 |
Why?
|
| Fellowships and Scholarships | 3 | 2025 | 321 | 0.350 |
Why?
|
| Middle Aged | 19 | 2025 | 28735 | 0.350 |
Why?
|
| Pseudotumor Cerebri | 1 | 2012 | 64 | 0.340 |
Why?
|
| Reproducibility of Results | 6 | 2021 | 2950 | 0.340 |
Why?
|
| Retrospective Studies | 15 | 2025 | 17485 | 0.330 |
Why?
|
| Optic Neuritis | 1 | 2010 | 34 | 0.320 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 996 | 0.320 |
Why?
|
| Optic Nerve Diseases | 1 | 2010 | 79 | 0.300 |
Why?
|
| Aged | 16 | 2025 | 21134 | 0.290 |
Why?
|
| Lymph Nodes | 2 | 2025 | 375 | 0.290 |
Why?
|
| Contrast Media | 4 | 2018 | 486 | 0.290 |
Why?
|
| Central Nervous System Diseases | 1 | 2009 | 98 | 0.290 |
Why?
|
| Laryngeal Neoplasms | 2 | 2022 | 85 | 0.280 |
Why?
|
| Adult | 16 | 2025 | 31541 | 0.270 |
Why?
|
| Calcinosis | 1 | 2009 | 185 | 0.270 |
Why?
|
| Male | 22 | 2025 | 64823 | 0.260 |
Why?
|
| Robotic Surgical Procedures | 2 | 2021 | 232 | 0.240 |
Why?
|
| Neuroradiography | 1 | 2025 | 5 | 0.240 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 2287 | 0.230 |
Why?
|
| Female | 22 | 2025 | 70755 | 0.220 |
Why?
|
| Population Surveillance | 2 | 2018 | 397 | 0.220 |
Why?
|
| Sarcoma, Alveolar Soft Part | 1 | 2003 | 10 | 0.200 |
Why?
|
| Tongue Neoplasms | 1 | 2003 | 30 | 0.200 |
Why?
|
| Education, Medical, Graduate | 2 | 2025 | 543 | 0.190 |
Why?
|
| Angiography | 1 | 2003 | 193 | 0.190 |
Why?
|
| Radiologists | 1 | 2022 | 52 | 0.180 |
Why?
|
| Image Enhancement | 1 | 2003 | 167 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2020 | 115 | 0.180 |
Why?
|
| Aged, 80 and over | 6 | 2020 | 6862 | 0.180 |
Why?
|
| Larynx | 1 | 2022 | 72 | 0.180 |
Why?
|
| Prognosis | 4 | 2022 | 4930 | 0.170 |
Why?
|
| Radiation Oncology | 1 | 2021 | 27 | 0.170 |
Why?
|
| Papillomaviridae | 2 | 2022 | 181 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 1302 | 0.170 |
Why?
|
| Skull Base Neoplasms | 1 | 2021 | 37 | 0.170 |
Why?
|
| Narrow Band Imaging | 1 | 2020 | 2 | 0.170 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2020 | 34 | 0.170 |
Why?
|
| Subcutaneous Emphysema | 1 | 2020 | 3 | 0.170 |
Why?
|
| Mediastinal Emphysema | 1 | 2020 | 11 | 0.160 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 48 | 0.160 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 1904 | 0.160 |
Why?
|
| Curriculum | 2 | 2025 | 776 | 0.160 |
Why?
|
| Emphysema | 1 | 2020 | 64 | 0.150 |
Why?
|
| Neurology | 1 | 2021 | 115 | 0.150 |
Why?
|
| Tonsillectomy | 1 | 2021 | 112 | 0.150 |
Why?
|
| Tobacco Smoking | 1 | 2018 | 20 | 0.150 |
Why?
|
| Proportional Hazards Models | 2 | 2019 | 1401 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2019 | 350 | 0.140 |
Why?
|
| Young Adult | 7 | 2020 | 10040 | 0.140 |
Why?
|
| Referral and Consultation | 2 | 2021 | 564 | 0.140 |
Why?
|
| Clinical Competence | 2 | 2021 | 1041 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2018 | 357 | 0.120 |
Why?
|
| Physician's Role | 1 | 2017 | 164 | 0.120 |
Why?
|
| Georgia | 2 | 2013 | 43 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1249 | 0.120 |
Why?
|
| Chemoradiotherapy | 3 | 2022 | 120 | 0.120 |
Why?
|
| Radiography | 3 | 2022 | 760 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2017 | 821 | 0.110 |
Why?
|
| Facial Nerve | 1 | 2014 | 25 | 0.110 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 40 | 0.110 |
Why?
|
| Neck Dissection | 1 | 2014 | 29 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 610 | 0.100 |
Why?
|
| Headache | 1 | 2014 | 110 | 0.100 |
Why?
|
| Empty Sella Syndrome | 1 | 2013 | 1 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2017 | 1441 | 0.100 |
Why?
|
| Perfusion Imaging | 1 | 2013 | 12 | 0.100 |
Why?
|
| Cerebral Angiography | 1 | 2013 | 105 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2022 | 1207 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2022 | 12858 | 0.090 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 4008 | 0.090 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 130 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 390 | 0.090 |
Why?
|
| Biomechanical Phenomena | 1 | 2012 | 263 | 0.090 |
Why?
|
| Time-to-Treatment | 1 | 2013 | 206 | 0.080 |
Why?
|
| Mycoses | 1 | 2011 | 112 | 0.080 |
Why?
|
| Histoplasmosis | 1 | 2010 | 55 | 0.080 |
Why?
|
| Sinusitis | 1 | 2011 | 117 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2013 | 261 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5257 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2018 | 6443 | 0.080 |
Why?
|
| Gadolinium | 1 | 2010 | 110 | 0.080 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 485 | 0.080 |
Why?
|
| Observer Variation | 1 | 2010 | 317 | 0.070 |
Why?
|
| Diagnostic Errors | 1 | 2013 | 340 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2013 | 530 | 0.070 |
Why?
|
| Algorithms | 1 | 2015 | 1680 | 0.070 |
Why?
|
| Adolescent | 6 | 2020 | 20814 | 0.060 |
Why?
|
| Accreditation | 1 | 2025 | 88 | 0.060 |
Why?
|
| Stroke | 1 | 2013 | 1041 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2010 | 702 | 0.050 |
Why?
|
| Incidence | 1 | 2012 | 3327 | 0.050 |
Why?
|
| Oral Hemorrhage | 1 | 2003 | 3 | 0.050 |
Why?
|
| Laryngectomy | 1 | 2022 | 31 | 0.050 |
Why?
|
| United States | 3 | 2025 | 11718 | 0.050 |
Why?
|
| Palatine Tonsil | 1 | 2021 | 35 | 0.040 |
Why?
|
| Skull Base | 1 | 2021 | 48 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 788 | 0.040 |
Why?
|
| Margins of Excision | 1 | 2021 | 56 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2025 | 957 | 0.040 |
Why?
|
| Head | 1 | 2021 | 115 | 0.040 |
Why?
|
| Morbidity | 1 | 2021 | 258 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2020 | 154 | 0.040 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 121 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2023 | 501 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2021 | 139 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 910 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1068 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 703 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 90 | 0.030 |
Why?
|
| Cerebral Revascularization | 1 | 2013 | 22 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2013 | 103 | 0.020 |
Why?
|
| Learning Curve | 1 | 2013 | 58 | 0.020 |
Why?
|
| Age Factors | 1 | 2018 | 2866 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 296 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 313 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3675 | 0.020 |
Why?
|
| Patient Selection | 1 | 2013 | 724 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2021 | 3120 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2016 | 14945 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 3433 | 0.010 |
Why?
|
| Child | 2 | 2016 | 26098 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 6275 | 0.010 |
Why?
|